Niagen Bioscience, Inc. (FRA:OCD1)
Germany · Delayed Price · Currency is EUR 4.740
-0.040 (-0.84%)
At close: Jan 30, 2026
-13.82% (1Y)
| Market Cap | 403.79M -5.9% |
| Revenue (ttm) | 106.29M +36.0% |
| Net Income | 17.41M +1,275.7% |
| EPS | 0.20 +1,093.8% |
| Shares Out | n/a |
| PE Ratio | 23.19 |
| Forward PE | 26.37 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 10 |
| Open | 4.740 |
| Previous Close | 4.780 |
| Day's Range | 4.740 - 4.740 |
| 52-Week Range | 4.720 - 12.400 |
| Beta | n/a |
| RSI | 39.31 |
| Earnings Date | Mar 5, 2026 |